367 related articles for article (PubMed ID: 24515922)
21. [Lung development and mesenchymal stem cells].
Waszak P; Thébaud B
Arch Pediatr; 2011 Jul; 18 Suppl 2():S86-91. PubMed ID: 21763980
[TBL] [Abstract][Full Text] [Related]
22. Cell surface structures influence lung clearance rate of systemically infused mesenchymal stromal cells.
Nystedt J; Anderson H; Tikkanen J; Pietilä M; Hirvonen T; Takalo R; Heiskanen A; Satomaa T; Natunen S; Lehtonen S; Hakkarainen T; Korhonen M; Laitinen S; Valmu L; Lehenkari P
Stem Cells; 2013 Feb; 31(2):317-26. PubMed ID: 23132820
[TBL] [Abstract][Full Text] [Related]
23. Mesenchymal stem cell therapy for heart disease.
Gnecchi M; Danieli P; Cervio E
Vascul Pharmacol; 2012 Aug; 57(1):48-55. PubMed ID: 22521741
[TBL] [Abstract][Full Text] [Related]
24. Minimally cultured bone marrow mesenchymal stem cells ameliorate fibrotic lung injury.
Kumamoto M; Nishiwaki T; Matsuo N; Kimura H; Matsushima K
Eur Respir J; 2009 Sep; 34(3):740-8. PubMed ID: 19324956
[TBL] [Abstract][Full Text] [Related]
25. Therapeutic Potential of Mesenchymal Stem Cells for the Treatment of Airway Remodeling in Pulmonary Diseases.
Nejad-Moghaddam A; Panahi Y; Abdollahpour Alitappeh M; Borna H; Shokrgozar MA; Ghanei M
Iran J Allergy Asthma Immunol; 2015 Dec; 14(6):552-68. PubMed ID: 26725553
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stem cells for systemic therapy: shotgun approach or magic bullets?
Millard SM; Fisk NM
Bioessays; 2013 Mar; 35(3):173-82. PubMed ID: 23184477
[TBL] [Abstract][Full Text] [Related]
27. Mesenchymal stem cells and their use in therapy: what has been achieved?
Fernández Vallone VB; Romaniuk MA; Choi H; Labovsky V; Otaegui J; Chasseing NA
Differentiation; 2013 Jan; 85(1-2):1-10. PubMed ID: 23314286
[TBL] [Abstract][Full Text] [Related]
28. Therapeutic potential of mesenchymal stromal cells for acute respiratory distress syndrome.
Matthay MA
Ann Am Thorac Soc; 2015 Mar; 12 Suppl 1(Suppl 1):S54-7. PubMed ID: 25830837
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic potential of mesenchymal stem cells for pulmonary complications associated with preterm birth.
Laube M; Stolzing A; Thome UH; Fabian C
Int J Biochem Cell Biol; 2016 May; 74():18-32. PubMed ID: 26928452
[TBL] [Abstract][Full Text] [Related]
30. Mitochondrial transfer of induced pluripotent stem cell-derived mesenchymal stem cells to airway epithelial cells attenuates cigarette smoke-induced damage.
Li X; Zhang Y; Yeung SC; Liang Y; Liang X; Ding Y; Ip MS; Tse HF; Mak JC; Lian Q
Am J Respir Cell Mol Biol; 2014 Sep; 51(3):455-65. PubMed ID: 24738760
[TBL] [Abstract][Full Text] [Related]
31. Stem cell therapy in pulmonary fibrosis.
Tzouvelekis A; Antoniadis A; Bouros D
Curr Opin Pulm Med; 2011 Sep; 17(5):368-73. PubMed ID: 21681099
[TBL] [Abstract][Full Text] [Related]
32. Mesenchymal stromal cells and chronic inflammatory bowel disease.
Algeri M; Conforti A; Pitisci A; Starc N; Tomao L; Bernardo ME; Locatelli F
Immunol Lett; 2015 Dec; 168(2):191-200. PubMed ID: 26170204
[TBL] [Abstract][Full Text] [Related]
33. The potential use of mesenchymal stem cells in stroke therapy--From bench to bedside.
Dulamea AO
J Neurol Sci; 2015 May; 352(1-2):1-11. PubMed ID: 25818674
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic mesenchymal stromal cells: where we are headed.
Hanley PJ
Methods Mol Biol; 2015; 1283():1-11. PubMed ID: 25537839
[TBL] [Abstract][Full Text] [Related]
35. Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis.
Volarevic V; Nurkovic J; Arsenijevic N; Stojkovic M
Stem Cells; 2014 Nov; 32(11):2818-23. PubMed ID: 25154380
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal stem cells: myths and reality.
Sarukhan A; Zanotti L; Viola A
Swiss Med Wkly; 2015; 145():w14229. PubMed ID: 26700966
[TBL] [Abstract][Full Text] [Related]
37. Lessons from genetically altered mesenchymal stem cells (MSCs): candidates for improved MSC-directed myocardial repair.
Alfaro MP; Young PP
Cell Transplant; 2012; 21(6):1065-74. PubMed ID: 22080676
[TBL] [Abstract][Full Text] [Related]
38. Mesenchymal stem cells in regenerative medicine for musculoskeletal diseases: bench, bedside, and industry.
Wei CC; Lin AB; Hung SC
Cell Transplant; 2014; 23(4-5):505-12. PubMed ID: 24816447
[TBL] [Abstract][Full Text] [Related]
39. Intraparenchymal injection of bone marrow mesenchymal stem cells reduces kidney fibrosis after ischemia-reperfusion in cyclosporine-immunosuppressed rats.
Alfarano C; Roubeix C; Chaaya R; Ceccaldi C; Calise D; Mias C; Cussac D; Bascands JL; Parini A
Cell Transplant; 2012; 21(9):2009-19. PubMed ID: 22525800
[TBL] [Abstract][Full Text] [Related]
40. Mesenchymal stem cell treatment for autoimmune diseases: a critical review.
Figueroa FE; Carrión F; Villanueva S; Khoury M
Biol Res; 2012; 45(3):269-77. PubMed ID: 23283436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
